🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

SARS-CoV-2 mRNA vaccination elicits a robust and persistent T follicular helper cell response in humans

Cell(2021)10.1016/j.cell.2021.12.026Source: DataRank Database

SARS-CoV-2 mRNA vaccination elicits a robust and persistent T follicular helper cell response in humans is a research paper published in Cell (2021). On theSindex it has a DataRank of 0.860. It has been cited 308 times.

N/A

0.860DataRank · unranked

Scored on demand from live citation data

Open Access308 citations

Cite:

Linked data & code

geo gen nct doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (24 grants)Impact (FWCI 15.05)OA: bronzeTopics (112)IDs (PubMed, PMC, OpenAlex)Annotations (4)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

DataRank Breakdown

Base Score 100%Citation Network 0%

Base Score Contribution

0.860

From this paper's citation signal

Citation Network Contribution

0

Citation network not refreshed for this result

This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.

Learn more about DataRank methodology →

Authors (61)

Anastasia A. Minervina ORCID,Mikhail V. Pogorelyy ORCID,Jackson S. Turner ORCID,Wooseob Kim ORCID,Elizaveta Kalaidina

Live enrichment

PubMed:35026152 PMC:PMC8695127 OpenAlex:https://openalex.org/W4200466458

National Health and Medical Research Council

Grant: 1173871

National Health and Medical Research Council

Grant: 1194036

Understanding immune responses to severe influenza virus infection and vaccination in humans

National Institute of Allergy and Infectious Diseases

Grant: 75N93019C00051

National Institute of Allergy and Infectious Diseases

Grant: 75N93019C00052

National Institute of Allergy and Infectious Diseases

Grant: U01AI141990

National Institute of Allergy and Infectious Diseases

Grant: HHSN272201400008C

National Institute of Allergy and Infectious Diseases

Grant: 75N93021C00016

NIAID NIH HHS

Grant: HHSN272201400006C

NIAID NIH HHS

Grant: U01 AI144616

NIAID NIH HHS

Grant: U01 AI150747

NCATS NIH HHS

Grant: UL1 TR002345

NIAID NIH HHS

Grant: R01 AI121832

NIAID NIH HHS

Grant: R01 AI136514

National Institutes of Health

Grant: 1U01AI150747-01

DYNAMICS AND EVOLUTION OF IMMUNE RESPONSES TO INFLUENZA VIRUSES

National Institutes of Health

Grant: 1UL1TR002345-01

Washington University Institute of Clinical and Translational Sciences

National Institutes of Health

Grant: 2U01AI141990-06

Programming Durable Immune Responses To Vaccination

National Institutes of Health

Grant: 3U01AI144616-03S1

Household Respiratory Virus SARS-CoV-2 Transmission and Immunity Sub-Study (HRTS)

National Institutes of Health

Grant: 5R01AI136514-05

Decoding the interactions between T cell receptors and peptide-MHC

Australian Research Council

AbbVie

American Lebanese Syrian Associated Charities

Johnson and Johnson

National Center for Advancing Translational Sciences

National Institutes of Health

FWCI

15.05

Citation Percentile

1.0%

Citation Trend

2021

2022

2023

2024

2025

2026

bronzeLicense: Elsevier Non-Commercial

journalhttp://www.cell.com/article/S0092867421014896/pdf

publisherhttp://www.cell.com/article/S0092867421014896/pdf

publisherhttps://api.elsevier.com/content/article/PII:S0092867421014896?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S0092867421014896?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.cell.2021.12.026

Fields of Study

SARS-CoV-2 and COVID-19 ResearchAnimal Virus Infections StudiesImmunotherapy and Immune Responses03 medical and health sciences0302 clinical medicineAdultB-LymphocytesBNT162 VaccineCOVID-19Clone CellsCohort StudiesCytokinesFemaleGerminal CenterHLA-DP beta-ChainsHumansImmunityImmunodominant EpitopesJurkat CellsLymph NodesMaleMiddle AgedPeptidesProtein MultimerizationReceptors, Antigen, T-CellSARS-CoV-2T Follicular Helper CellsVaccinationVaccines, SyntheticmRNA Vaccines

MeSH Terms

T Follicular Helper CellsCOVID-19SARS-CoV-2mRNA VaccinesBNT162 VaccineAdultB-LymphocytesClone CellsFemaleHumansImmunityLymph NodesMaleMiddle AgedPeptidesReceptors, Antigen, T-CellVaccinationVaccines, SyntheticCohort StudiesImmunodominant EpitopesCytokinesGerminal CenterJurkat CellsProtein MultimerizationHLA-DP beta-Chains

Keywords

BiologyVaccinationAntibody responseVirologyMessenger RNAImmunologyCoronavirus disease 2019 (COVID-19)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)AntibodyFollicular phase2019-20 coronavirus outbreakT helper cellT cellImmune systemGeneticsOutbreakGeneInfectious disease (medical specialty)Internal medicineLymph NodeTcr RepertoireT Follicular Helper CellHuman ImmunologyMrna VaccinationCd4(+) T cellCovid-19Sars-cov-2AdultMaleT Follicular Helper CellsReceptors, Antigen, T-Cell610ArticleCohort StudiesJurkat Cells616ReceptorsCD4(+) T cellHumansBNT162 VaccineHLA-DP beta-ChainsVaccinesB-LymphocytesImmunodominant EpitopesSyntheticImmunityMiddle AgedT-CellGerminal CenterClone CellsAntigenCytokinesFemalemRNA VaccinesLymph NodesProtein MultimerizationPeptides

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being

Related Papers (10)

Imbalance of Regulatory and Cytotoxic SARS-CoV-2-Reactive CD4+ T Cells in COVID-19

N/A

0.960DataRank · unranked

Cell(2020)

co-citedsame journal

10.1016/j.cell.2020.10.001

Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine

N/A

1.4DataRank · unranked

New England Journal of Medicine(2020)

co-cited

10.1056/nejmoa2034577

Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation

N/A

1.4DataRank · unranked

Science(2020)

co-cited

10.1126/science.abb2507

Predicting antigen specificity of single T cells based on TCR CDR 3 regions

N/A

0.722DataRank · unranked

Molecular Systems Biology(2020)

co-cited

10.15252/msb.20199416

A guide to cancer immunotherapy: from T cell basic science to clinical practice

N/A

1.3DataRank · unranked

Nature reviews. Immunology(2020)

co-cited

10.1038/s41577-020-0306-5

SARS-CoV-2 mRNA vaccine design enabled by prototype pathogen preparedness

N/A

12.4DataRank · unranked

Nature(2020)

co-cited

10.1038/s41586-020-2622-0

Distinct conformational states of SARS-CoV-2 spike protein

N/A

1.1DataRank · unranked

Science(2020)

co-cited

10.1126/science.abd4251

Pre-existing immunity to SARS-CoV-2: the knowns and unknowns

N/A

0.900DataRank · unranked

Nature reviews. Immunology(2020)

co-cited

10.1038/s41577-020-0389-z

Next-generation vaccine platforms for COVID-19

N/A

0.893DataRank · unranked

Nature Materials(2020)

co-cited

10.1038/s41563-020-0746-0

Dynamic changes in circulating T follicular helper cell composition predict neutralising antibody responses after yellow fever vaccination

Clinical & Translational Immunology(2020)

co-cited

10.1002/cti2.1129